Global Autoimmune Disease Diagnostics Market 2021-2031

Bonafide Trust 02-02-2022 188 Pages
Region : Global Category : Lifescience Medical Devices

Request new version

Request for updated version of the report at the same price

Order Now

Report Description
Table of Contents
List of Figure Tables

Global autoimmune disease diagnostics market will reach $10.81 billion by 2031, growing by 8.1% annually over 2021-2031, driven by the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies. Highlighted with 87 tables and 103 figures, this 188-page report “Global Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Region. Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Assay Kits & Consumables • Analyzers & Instruments Based on Test Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Autoantibodies and Immunologic Tests • Antinuclear Antibody Tests • Anti-cyclic Citrullinated Peptide • Enzyme-Linked Immunosorbent Assay (ELISA) • Rheumatoid Factor • Thyroid Antibody Tests • Other Autoantibodies and Immunologic Tests • Inflammatory Marker Tests • C-Reactive Protein (CRP) • Erythrocyte Sedimentation Rate (ESR) • Other Inflammatory Marker Tests • Routine Laboratory Tests • Urinalysis • Complete Blood Count (CBC) Tests • Other Routine Laboratory Tests • Other Test Types Based on Disease Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Systemic Autoimmune Disease • Rheumatoid Arthritis • Systemic Lupus Erythematosus (SLE) • Psoriasis/Psoriatic Arthritis • Other Systemic Autoimmune Diseases • Localized Autoimmune Disease • Thyroiditis • Multiple Sclerosis • Inflammatory Bowel Disease • Type 1 Diabetes • Other Localized Autoimmune Diseases Based on Gender, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Female Patients • Male Patients Based on Age, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • < 44 • 44 - 64 • > 64 Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Diagnostic Labs • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa, Other Nations) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories Beckman Coulter, Inc. Biomerieux SA Bio-rad Laboratories Inc. F. Hoffmann-la Roche Ltd. Hemagen Diagnostics Inc. Myriad Genetics Inc. PerkinElmer Inc. (Euroimmun AG) Quest Diagnostics Inc. Siemens Healthineers Inc. Thermo Fisher Scientific Inc. Trinity Biotech PLC Werfen Company (Inova Diagnostics Inc.) (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 11

1.1 Industry Definition and Research Scope 11

1.1.1 Industry Definition 11

1.1.2 Research Scope 12

1.2 Research Methodology 15

1.2.1 Overview of Market Research Methodology 15

1.2.2 Market Assumption 16

1.2.3 Secondary Data 16

1.2.4 Primary Data 16

1.2.5 Data Filtration and Model Design 17

1.2.6 Market Size/Share Estimation 18

1.2.7 Research Limitations 19

1.3 Executive Summary 20

2 Market Overview and Dynamics 23

2.1 Market Size and Forecast 23

2.1.1 Impact of COVID-19 on World Economy 24

2.1.2 Impact of COVID-19 on the Market 26

2.2 Major Growth Drivers 28

2.3 Market Restraints and Challenges 33

2.4 Emerging Opportunities and Market Trends 36

2.5 Porter’s Fiver Forces Analysis 40

3 Segmentation of Global Market by Product 45

3.1 Market Overview by Product 45

3.2 Assay Kits & Consumables 47

3.3 Analyzers & Instruments 48

4 Segmentation of Global Market by Test Type 49

4.1 Market Overview by Test Type 49

4.2 Autoantibodies and Immunologic Tests 51

4.2.1 Antinuclear Antibody Tests 53

4.2.2 Anti-cyclic Citrullinated Peptide 54

4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 55

4.2.4 Rheumatoid Factor 56

4.2.5 Thyroid Antibody Tests 57

4.2.6 Other Autoantibodies and Immunologic Tests 58

4.3 Inflammatory Marker Tests 59

4.3.1 C-Reactive Protein (CRP) 61

4.3.2 Erythrocyte Sedimentation Rate (ESR) 62

4.3.3 Other Inflammatory Marker Tests 63

4.4 Routine Laboratory Tests 64

4.4.1 Urinalysis 66

4.4.2 Complete Blood Count (CBC) Tests 67

4.4.3 Other Routine Laboratory Tests 68

4.5 Other Test Types 69

5 Segmentation of Global Market by Disease Type 70

5.1 Market Overview by Disease Type 70

5.2 Systemic Autoimmune Disease 72

5.2.1 Rheumatoid Arthritis 74

5.2.2 Systemic Lupus Erythematosus (SLE) 75

5.2.3 Psoriasis/Psoriatic Arthritis 76

5.2.4 Other Systemic Autoimmune Diseases 77

5.3 Localized Autoimmune Disease 78

5.3.1 Thyroiditis 80

5.3.2 Multiple Sclerosis 81

5.3.3 Inflammatory Bowel Disease 82

5.3.4 Type 1 Diabetes 83

5.3.5 Other Localized Autoimmune Diseases 84

6 Segmentation of Global Market by Gender 85

6.1 Market Overview by Gender 85

6.2 Female Patients 87

6.3 Male Patients 88

7 Segmentation of Global Market by Age 89

7.1 Market Overview by Age 89

7.2 < 44 91

7.3 44 - 64 92

7.4 > 64 93

8 Segmentation of Global Market by End User 94

8.1 Market Overview by End User 94

8.2 Hospitals 96

8.3 Clinics 97

8.4 Diagnostic Labs 98

8.5 Other End Users 99

9 Segmentation of Global Market by Region 100

9.1 Geographic Market Overview 2021-2031 100

9.2 North America Market 2021-2031 by Country 104

9.2.1 Overview of North America Market 104

9.2.2 U.S. 108

9.2.3 Canada 111

9.2.4 Mexico 113

9.3 European Market 2021-2031 by Country 115

9.3.1 Overview of European Market 115

9.3.2 Germany 119

9.3.3 U.K. 121

9.3.4 France 123

9.3.5 Spain 125

9.3.6 Italy 127

9.3.7 Russia 129

9.3.8 Rest of European Market 131

9.4 Asia-Pacific Market 2021-2031 by Country 133

9.4.1 Overview of Asia-Pacific Market 133

9.4.2 Japan 137

9.4.3 China 140

9.4.4 Australia 142

9.4.5 India 144

9.4.6 South Korea 146

9.4.7 Rest of APAC Region 148

9.5 South America Market 2021-2031 by Country 150

9.5.1 Argentina 153

9.5.2 Brazil 155

9.5.3 Chile 157

9.5.4 Rest of South America Market 159

9.6 MEA Market 2021-2031 by Country 160

9.6.1 UAE 163

9.6.2 Saudi Arabia 165

9.6.3 South Africa 167

9.6.4 Other National Markets 169

10 Competitive Landscape 170

10.1 Overview of Key Vendors 170

10.2 New Product Launch, Partnership, Investment, and M&A 173

10.3 Company Profiles 174

Abbott Laboratories 174

Beckman Coulter, Inc. 176

Biomerieux SA 177

Bio-rad Laboratories Inc. 178

F. Hoffmann-la Roche Ltd. 179

Hemagen Diagnostics Inc. 180

Myriad Genetics Inc. 181

PerkinElmer Inc. (Euroimmun AG) 182

Quest Diagnostics Inc. 183

Siemens Healthineers Inc. 184

Thermo Fisher Scientific Inc. 185

Trinity Biotech PLC 186

Werfen Company (Inova Diagnostics Inc.) 187

RELATED REPORTS 188

List of Figures:

Figure 1. Research Method Flow Chart 15
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 20
Figure 4. Global Autoimmune Disease Diagnostics Market, 2021-2031, $ mn 23
Figure 5. Impact of COVID-19 on Business 26
Figure 6. Primary Drivers and Impact Factors of Global Autoimmune Disease Diagnostics Market 28
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 31
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 31
Figure 9. Primary Restraints and Impact Factors of Global Autoimmune Disease Diagnostics Market 33
Figure 10. Investment Opportunity Analysis 37
Figure 11. Porter’s Fiver Forces Analysis of Global Autoimmune Disease Diagnostics Market 40
Figure 12. Breakdown of Global Autoimmune Disease Diagnostics Market by Product, 2021-2031, % of Revenue 46
Figure 13. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 46
Figure 14. Global Autoimmune Disease Diagnostics Market by Product: Assay Kits & Consumables, 2021-2031, $ mn 47
Figure 15. Global Autoimmune Disease Diagnostics Market by Product: Analyzers & Instruments, 2021-2031, $ mn 48
Figure 16. Breakdown of Global Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, % of Sales Revenue 50
Figure 17. Global Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%) 50
Figure 18. Global Autoimmune Disease Diagnostics Market by Test Type: Autoantibodies and Immunologic Tests, 2021-2031, $ mn 51
Figure 19. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Antinuclear Antibody Tests, 2021-2031, $ mn 53
Figure 20. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Anti-cyclic Citrullinated Peptide, 2021-2031, $ mn 54
Figure 21. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Enzyme-Linked Immunosorbent Assay (ELISA), 2021-2031, $ mn 55
Figure 22. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Rheumatoid Factor, 2021-2031, $ mn 56
Figure 23. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Thyroid Antibody Tests, 2021-2031, $ mn 57
Figure 24. Global Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Other Autoantibodies and Immunologic Tests, 2021-2031, $ mn 58
Figure 25. Global Autoimmune Disease Diagnostics Market by Test Type: Inflammatory Marker Tests, 2021-2031, $ mn 59
Figure 26. Global Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: C-Reactive Protein (CRP), 2021-2031, $ mn 61
Figure 27. Global Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Erythrocyte Sedimentation Rate (ESR), 2021-2031, $ mn 62
Figure 28. Global Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Other Inflammatory Marker Tests, 2021-2031, $ mn 63
Figure 29. Global Autoimmune Disease Diagnostics Market by Test Type: Routine Laboratory Tests, 2021-2031, $ mn 64
Figure 30. Global Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Urinalysis, 2021-2031, $ mn 66
Figure 31. Global Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Complete Blood Count (CBC) Tests, 2021-2031, $ mn 67
Figure 32. Global Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Other Routine Laboratory Tests, 2021-2031, $ mn 68
Figure 33. Global Autoimmune Disease Diagnostics Market by Test Type: Other Test Types, 2021-2031, $ mn 69
Figure 34. Breakdown of Global Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, % of Sales Revenue 71
Figure 35. Global Addressable Market Cap in 2022-2031 by Disease Type, Value ($ mn) and Share (%) 71
Figure 36. Global Autoimmune Disease Diagnostics Market by Disease Type: Systemic Autoimmune Disease, 2021-2031, $ mn 72
Figure 37. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Rheumatoid Arthritis, 2021-2031, $ mn 74
Figure 38. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Systemic Lupus Erythematosus (SLE), 2021-2031, $ mn 75
Figure 39. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Psoriasis/Psoriatic Arthritis, 2021-2031, $ mn 76
Figure 40. Global Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Other Systemic Autoimmune Diseases, 2021-2031, $ mn 77
Figure 41. Global Autoimmune Disease Diagnostics Market by Disease Type: Localized Autoimmune Disease, 2021-2031, $ mn 78
Figure 42. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Thyroiditis, 2021-2031, $ mn 80
Figure 43. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Multiple Sclerosis, 2021-2031, $ mn 81
Figure 44. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Inflammatory Bowel Disease, 2021-2031, $ mn 82
Figure 45. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Type 1 Diabetes, 2021-2031, $ mn 83
Figure 46. Global Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Other Localized Autoimmune Diseases, 2021-2031, $ mn 84
Figure 47. Breakdown of Global Autoimmune Disease Diagnostics Market by Gender, 2021-2031, % of Revenue 86
Figure 48. Global Addressable Market Cap in 2022-2031 by Gender, Value ($ mn) and Share (%) 86
Figure 49. Global Autoimmune Disease Diagnostics Market by Gender: Female Patients, 2021-2031, $ mn 87
Figure 50. Global Autoimmune Disease Diagnostics Market by Gender: Male Patients, 2021-2031, $ mn 88
Figure 51. Breakdown of Global Autoimmune Disease Diagnostics Market by Age, 2021-2031, % of Revenue 90
Figure 52. Global Addressable Market Cap in 2022-2031 by Age, Value ($ mn) and Share (%) 90
Figure 53. Global Autoimmune Disease Diagnostics Market by Age: < 44, 2021-2031, $ mn 91
Figure 54. Global Autoimmune Disease Diagnostics Market by Age: 44 - 64, 2021-2031, $ mn 92
Figure 55. Global Autoimmune Disease Diagnostics Market by Age: > 64, 2021-2031, $ mn 93
Figure 56. Breakdown of Global Autoimmune Disease Diagnostics Market by End User, 2021-2031, % of Revenue 94
Figure 57. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 95
Figure 58. Global Autoimmune Disease Diagnostics Market by End User: Hospitals, 2021-2031, $ mn 96
Figure 59. Global Autoimmune Disease Diagnostics Market by End User: Clinics, 2021-2031, $ mn 97
Figure 60. Global Autoimmune Disease Diagnostics Market by End User: Diagnostic Labs, 2021-2031, $ mn 98
Figure 61. Global Autoimmune Disease Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 99
Figure 62. Global Market Snapshot by Region 100
Figure 63. Geographic Spread of Worldwide Autoimmune Disease Diagnostics Market, 2021-2031, % of Sales Revenue 101
Figure 64. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 102
Figure 65. North American Autoimmune Disease Diagnostics Market, 2021-2031, $ mn 105
Figure 66. Breakdown of North America Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 106
Figure 67. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 107
Figure 68. U.S. Autoimmune Disease Diagnostics Market, 2021-2031, $ mn 109
Figure 69. Canada Autoimmune Disease Diagnostics Market, 2021-2031, $ mn 111
Figure 70. Autoimmune Disease Diagnostics Market in Mexico, 2021-2031, $ mn 113
Figure 71. European Autoimmune Disease Diagnostics Market, 2021-2031, $ mn 116
Figure 72. Breakdown of European Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 117
Figure 73. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 118
Figure 74. Autoimmune Disease Diagnostics Market in Germany, 2021-2031, $ mn 119
Figure 75. Autoimmune Disease Diagnostics Market in U.K., 2021-2031, $ mn 121
Figure 76. Autoimmune Disease Diagnostics Market in France, 2021-2031, $ mn 123
Figure 77. Autoimmune Disease Diagnostics Market in Spain, 2021-2031, $ mn 125
Figure 78. Autoimmune Disease Diagnostics Market in Italy, 2021-2031, $ mn 127
Figure 79. Autoimmune Disease Diagnostics Market in Russia, 2021-2031, $ mn 129
Figure 80. Autoimmune Disease Diagnostics Market in Rest of Europe, 2021-2031, $ mn 131
Figure 81. Asia-Pacific Autoimmune Disease Diagnostics Market, 2021-2031, $ mn 134
Figure 82. Breakdown of APAC Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 134
Figure 83. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 136
Figure 84. Autoimmune Disease Diagnostics Market in Japan, 2021-2031, $ mn 138
Figure 85. Autoimmune Disease Diagnostics Market in China, 2021-2031, $ mn 140
Figure 86. Autoimmune Disease Diagnostics Market in Australia, 2021-2031, $ mn 142
Figure 87. Autoimmune Disease Diagnostics Market in India, 2021-2031, $ mn 144
Figure 88. Autoimmune Disease Diagnostics Market in South Korea, 2021-2031, $ mn 146
Figure 89. Autoimmune Disease Diagnostics Market in Rest of APAC, 2021-2031, $ mn 148
Figure 90. South America Autoimmune Disease Diagnostics Market, 2021-2031, $ mn 151
Figure 91. Breakdown of South America Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 151
Figure 92. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 152
Figure 93. Autoimmune Disease Diagnostics Market in Argentina, 2021-2031, $ mn 153
Figure 94. Autoimmune Disease Diagnostics Market in Brazil, 2021-2031, $ mn 155
Figure 95. Autoimmune Disease Diagnostics Market in Chile, 2021-2031, $ mn 157
Figure 96. Autoimmune Disease Diagnostics Market in Rest of South America, 2021-2031, $ mn 159
Figure 97. Autoimmune Disease Diagnostics Market in Middle East and Africa (MEA), 2021-2031, $ mn 161
Figure 98. Breakdown of MEA Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 161
Figure 99. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 162
Figure 100. Autoimmune Disease Diagnostics Market in UAE, 2021-2031, $ mn 163
Figure 101. Autoimmune Disease Diagnostics Market in Saudi Arabia, 2021-2031, $ mn 165
Figure 102. Autoimmune Disease Diagnostics Market in South Africa, 2021-2031, $ mn 167
Figure 103. Growth Stage of Global Autoimmune Disease Diagnostics Industry over the Forecast Period 170

List of Tables:

Table 1. Snapshot of Global Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031 21
Table 2. World Economic Outlook, 2021-2031 25
Table 3. World Health Spending by Region, $ bn, 2013-2020 32
Table 4. Main Product Trends and Market Opportunities in Global Autoimmune Disease Diagnostics Market 36
Table 5. Global Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 45
Table 6. Global Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, $ mn 49
Table 7. Global Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, $ mn 52
Table 8. Global Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, $ mn 60
Table 9. Global Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, $ mn 65
Table 10. Global Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 70
Table 11. Global Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, $ mn 73
Table 12. Global Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, $ mn 79
Table 13. Global Autoimmune Disease Diagnostics Market by Gender, 2021-2031, $ mn 85
Table 14. Global Autoimmune Disease Diagnostics Market by Age, 2021-2031, $ mn 89
Table 15. Global Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 94
Table 16. Global Autoimmune Disease Diagnostics Market by Region, 2021-2031, $ mn 101
Table 17. Leading National Autoimmune Disease Diagnostics Market, 2021 and 2031, $ mn 103
Table 18. North America Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 106
Table 19. U.S. Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 110
Table 20. U.S. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 110
Table 21. U.S. Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 110
Table 22. Canada Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 112
Table 23. Canada Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 112
Table 24. Canada Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 112
Table 25. Mexico Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 114
Table 26. Mexico Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 114
Table 27. Mexico Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 114
Table 28. Europe Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 118
Table 29. Germany Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 120
Table 30. Germany Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 120
Table 31. Germany Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 120
Table 32. U.K. Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 122
Table 33. U.K. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 122
Table 34. U.K. Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 122
Table 35. France Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 124
Table 36. France Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 124
Table 37. France Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 124
Table 38. Spain Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 126
Table 39. Spain Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 126
Table 40. Spain Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 126
Table 41. Italy Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 128
Table 42. Italy Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 128
Table 43. Italy Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 128
Table 44. Russia Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 130
Table 45. Russia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 130
Table 46. Russia Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 130
Table 47. Autoimmune Disease Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn 132
Table 48. APAC Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 135
Table 49. Japan Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 139
Table 50. Japan Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 139
Table 51. Japan Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 139
Table 52. China Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 141
Table 53. China Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 141
Table 54. China Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 141
Table 55. Australia Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 143
Table 56. Australia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 143
Table 57. Australia Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 143
Table 58. India Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 145
Table 59. India Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 145
Table 60. India Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 145
Table 61. South Korea Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 147
Table 62. South Korea Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 147
Table 63. South Korea Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 147
Table 64. Autoimmune Disease Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 149
Table 65. South America Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 152
Table 66. Argentina Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 154
Table 67. Argentina Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 154
Table 68. Argentina Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 154
Table 69. Brazil Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 156
Table 70. Brazil Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 156
Table 71. Brazil Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 156
Table 72. Chile Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 158
Table 73. Chile Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 158
Table 74. Chile Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 158
Table 75. MEA Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn 162
Table 76. UAE Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 164
Table 77. UAE Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 164
Table 78. UAE Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 164
Table 79. Saudi Arabia Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 166
Table 80. Saudi Arabia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 166
Table 81. Saudi Arabia Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 166
Table 82. South Africa Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn 168
Table 83. South Africa Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn 168
Table 84. South Africa Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn 168
Table 85. Abbott Laboratories: Company Snapshot 174
Table 86. Abbott Laboratories: Business Segmentation 175
Table 87. Abbott Laboratories: Product Portfolio 175

Interested in this report?
Get your FREE sample!

Safe and Secure SSl Encryption

Licensing options

3100
USD

Single User License
Site License
Global User License

How client has rates us?

Requirement Gathering & Methodology

Data Collection Techniques

Our Research Team & Data Sourcing

Data Science & Analytical Tools

Data Visualization & Presentation Skills

Project/ Report Delivery & After Sales Services

Testimonial

READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.

PRODUCT DEVELOPMENT MANAGER

CEO

Vivek Arora

BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!

EXECUTIVE DIRECTOR

Rahul Roy

THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.

SALES DIRECTOR

Arjun Prasad

THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH

MARKETING MANAGER

President

Manish Verma

Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

MARKETING DIRECTOR

Gautam Saxena

The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.

PRODUCT MANAGER

Tom Stone

I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.

Associate Director

Mark Wood

Global Autoimmune Disease Diagnostics Market 2021-2031

Global Autoimmune Disease Diagnostics Market 2021-2031